Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 4, 2010 - Issue 4
Submit an article Journal homepage
120
Views
17
CrossRef citations to date
0
Altmetric
Drug Profile

Aztreonam lysine: a novel inhalational antibiotic for cystic fibrosis

Michael D Parkins Department of Medicine, University of Calgary and Alberta Health Services, Calgary, Alberta, Canada; Department of Microbiology and Infectious Disease, University of Calgary and Alberta Health Services, Calgary, Alberta, Canada; North Ireland Adult Cystic Fibrosis Centre, Level 8, Belfast City Hospital, Belfast Health and Social Trust, Belfast, BT9 7AB, UK; Department of Medicine, University of Calgary and Alberta Health Services, Calgary, Alberta, Canada; Department of Microbiology and Infectious Disease, University of Calgary and Alberta Health Services, Calgary, Alberta, Canada; North Ireland Adult Cystic Fibrosis Centre, Level 8, Belfast City Hospital, Belfast Health and Social Trust, Belfast, BT9 7AB, UK
&
J Stuart Elborn North Ireland Adult Cystic Fibrosis Centre, Level 8, Belfast City Hospital, Belfast Health and Social Trust, Belfast, BT9 7AB, UK; Center for Infection and Immunity, Queen’s University, Belfast, UK. [email protected]; Center for Infection and Immunity, Queen’s University, Belfast, UK. [email protected]
Pages 435-444 | Published online: 09 Jan 2014

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Arzu Ari & James B Fink. (2020) Recent advances in aerosol devices for the delivery of inhaled medications. Expert Opinion on Drug Delivery 17:2, pages 133-144.
Read now
Paul Zarogoulidis, Ioannis Kioumis, Konstantinos Porpodis, Dionysios Spyratos, Kosmas Tsakiridis, Haidong Huang, Qiang Li, J Francis Turner, Robert Browning, Wolfgang Hohenforst-Schmidt & Konstantinos Zarogoulidis. (2013) Clinical experimentation with aerosol antibiotics: current and future methods of administration. Drug Design, Development and Therapy 7, pages 1115-1134.
Read now
Michael D Parkins & J Stuart Elborn. (2011) Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis. Expert Review of Respiratory Medicine 5:5, pages 609-622.
Read now

Articles from other publishers (14)

María Díez-Aguilar, Miquel Ekkelenkamp, María-Isabel Morosini, Natalia Huertas, Rosa del Campo, Javier Zamora, Ad C Fluit, Michael M Tunney, Daniel Obrecht, Francesca Bernardini & Rafael Cantón. (2021) Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates . Journal of Antimicrobial Chemotherapy 76:10, pages 2578-2585.
Crossref
Giovanni Taccetti, Michela Francalanci, Giovanna Pizzamiglio, Barbara Messore, Vincenzo Carnovale, Giuseppe Cimino & Marco Cipolli. (2021) Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives. Antibiotics 10:3, pages 338.
Crossref
Benjamin A Pontefract, Hong T Ho, Alexandria Crain, Madan K Kharel & S Eric Nybo. (2020) Drugs for Gram-Negative Bugs From 2010–2019: A Decade in Review. Open Forum Infectious Diseases 7:7.
Crossref
Elizabeth Claire Elson, Joel Mermis, Deepika Polineni & Christopher M Oermann. (2019) Aztreonam Lysine Inhalation Solution in Cystic Fibrosis. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 13, pages 117954841984282.
Crossref
Stefano Ponzano, Giulia Nigrelli, Laura Fregonese, Irmgard Eichler, Fabio Bertozzi, Tiziano Bandiera, Luis J.V. Galietta & Marisa Papaluca. (2018) A European regulatory perspective on cystic fibrosis: current treatments, trends in drug development and translational challenges for CFTR modulators. European Respiratory Review 27:148, pages 170124.
Crossref
Anthony De Soyza & Craig Winstanley. 2018. Bronchiectasis. Bronchiectasis 157 180 .
David CipollaHak-Kim Chan. (2013) Inhaled antibiotics to treat lung infection. Pharmaceutical Patent Analyst 2:5, pages 647-663.
Crossref
Carla López-Causapé, Estrella Rojo-Molinero, Xavier Mulet, Gabriel Cabot, Bartolomé Moyà, Joan Figuerola, Bernat Togores, José L. Pérez & Antonio Oliver. (2013) Clonal Dissemination, Emergence of Mutator Lineages and Antibiotic Resistance Evolution in Pseudomonas aeruginosa Cystic Fibrosis Chronic Lung Infection. PLoS ONE 8:8, pages e71001.
Crossref
Silvia Garazzino, Irja Lutsar, Chiara Bertaina, Pier-Angelo Tovo & Mike Sharland. (2013) New antibiotics for paediatric use: A review of a decade of regulatory trials submitted to the European Medicines Agency from 2000—Why aren’t we doing better?. International Journal of Antimicrobial Agents 42:2, pages 99-118.
Crossref
Eric W Alton, Jane C Davies & Uta GriesenbachJ Stuart Elborn. 2013. Current & Emerging Pharmaceutical Treatments for Cystic Fibrosis Lung Disease. Current & Emerging Pharmaceutical Treatments for Cystic Fibrosis Lung Disease 70 80 .
John LamSteven VaughanMichael D. Parkins. (2013) Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis . Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 7, pages CCRPM.S10592.
Crossref
Q. Yu, E. F. Griffin, S. Moreau-Marquis, J. D. Schwartzman, B. A. Stanton & G. A. O'Toole. (2012) In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells. Journal of Antimicrobial Chemotherapy 67:11, pages 2673-2681.
Crossref
Chad J Roy, Alida Ault, Satheesh K Sivasubramani, J Patrick Gorres, Chih-Jen Wei, Hanne Andersen, Jason Gall, Mario Roederer & Srinivas S Rao. (2011) Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method. Respiratory Research 12:1.
Crossref
Ryan Hudson & Brooke Olson Blair. (2011) Inhaled antibiotics for Gram-negative respiratory infections. Future Medicinal Chemistry 3:13, pages 1663-1677.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.